Buy Semaglutide Peptide 8mg — Synedica GLP-1 Injection Pen Kit
The Synedica Semaglutide 8mg Injection Pen Kit is the most convenient way to buy semaglutide peptide for structured laboratory and R&D research. Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1) — one of the most extensively studied metabolic research peptides in existence — with a 94% sequence homology to endogenous human GLP-1 and a prolonged half-life engineered for once-weekly administration in research protocols.
Pre-loaded across 2 precision pens, ready to use immediately. No reconstitution, no bacteriostatic water, no vial measuring. The Synedica kit delivers a configurable 8mg total — 4mg per pen — at doses from 0.25mg to 1mg per administration, making it the cleanest, most consistent format to buy semaglutide peptide for 12-week research protocols.
What Is Semaglutide Peptide?
Semaglutide (CAS: 910463-68-2, molecular formula: C187H291N45O59, molecular weight: 4113.6 Da) is a synthetic GLP-1 receptor agonist — a fatty acid-modified analog of human GLP-1 with 94% amino acid sequence homology to the endogenous hormone. Its structural modifications include a C18 fatty diacid chain attached via a linker to lysine at position 26, which enables albumin binding and confers a prolonged half-life of approximately 7 days — ideal for once-weekly dosing in research protocols.
In controlled laboratory research, semaglutide is investigated for its role in GLP-1 receptor binding and activation, glucose-dependent insulin secretion stimulation, glucagon suppression, gastric emptying modulation, and appetite signalling regulation. It is commercially known as Ozempic (diabetes indication) and Wegovy (obesity/weight management indication) in pharmaceutical form. Research-grade semaglutide peptide is available as a laboratory compound for controlled R&D use only.
Semaglutide vs Tirzepatide vs Retatrutide — Research Comparison
| Compound | Receptors | Class | Brand name | Synedica kit |
|---|---|---|---|---|
| Semaglutide | GLP-1 | Single agonist | Ozempic / Wegovy | 8mg pen kit |
| Tirzepatide | GLP-1 + GIP | Dual agonist | Mounjaro / Zepbound | 40mg pen kit |
| Retatrutide | GLP-1 + GIP + Glucagon | Triple agonist | Phase 3 trials (2026) | 40mg pen kit |
Most researchers begin with semaglutide (single GLP-1 agonist) to establish baseline GLP-1 receptor activity data before progressing to tirzepatide or retatrutide for comparative dual and triple-agonist studies. The Synedica pen kit range covers all three compounds in a consistent, reconstitution-free format.
Dose Configuration & Research Protocol Guide
The Synedica Semaglutide kit includes 2 pre-loaded 4mg pens — 8mg total — with full dose configurability at 0.25mg, 0.5mg, 0.75mg, and 1mg per administration. The standard research escalation protocol begins at 0.25mg for weeks 1–4, advances to 0.5mg for weeks 5–8, and may increase to 0.75mg or 1mg from week 9 — supporting a full 12-week research window from a single kit.
| Dose Setting | Per dose | Doses per pen | Total per kit |
|---|---|---|---|
| 0.25mg | 0.25mg Semaglutide | 16 doses | 32 doses |
| 0.5mg | 0.5mg Semaglutide | 8 doses | 16 doses |
| 0.75mg | 0.75mg Semaglutide | 5 doses | 10 doses |
| 1mg | 1mg Semaglutide | 4 doses | 8 doses |
What Is Included in the Semaglutide Pen Kit?
- 2 × Pre-loaded 4mg Semaglutide injection pens (8mg total)
- 12 × Disposable 32 gauge 4mm needles
- 1 × Full instruction and dosing guide booklet
Why Buy Semaglutide Peptide in Pen Format?
Most suppliers sell semaglutide peptide as a lyophilized powder requiring reconstitution with bacteriostatic water, separate syringes, and precise dose calculation. When you buy semaglutide peptide in the Synedica pen format, every preparation step is eliminated — pre-loaded, pre-measured, and consistent across every administration. No vials, no mixing, no measuring errors.
- 2 pre-loaded 4mg pens — 8mg total, zero preparation required
- 94% GLP-1 sequence homology — the same compound as Ozempic/Wegovy in research grade
- No reconstitution — no bacteriostatic water, no syringes, no measuring equipment
- All-in-one kit — 2 pens, 12 needles, and dosing guide all included
- 12-week research window — full escalation protocol supported from a single kit
- Fast USA shipping — in stock, dispatched within 1 business day
R&D Applications
The Synedica Semaglutide 8mg Injection Pen Kit is produced exclusively for the following controlled research and development applications:
- GLP-1 receptor binding affinity and activation pathway studies
- Glucose-dependent insulin secretion and pancreatic beta-cell function research
- Glucagon suppression and hepatic glucose output pathway investigation
- Gastric emptying modulation and appetite signalling studies
- GLP-1 pharmacokinetics, half-life, and fatty acid linker stability research
- Baseline single-agonist models for comparative GLP-1/GIP/Glucagon research
- Peptide formulation development and bioavailability evaluation
Frequently Asked Questions
Where can I buy semaglutide peptide in pen kit format?
The Synedica Semaglutide 8mg Injection Pen Kit is available directly at synedica.us. It is one of the only pre-loaded semaglutide peptide pen kits available to buy online for research applications — no reconstitution required. In stock with fast USA shipping.
What is semaglutide peptide?
Semaglutide (CAS: 910463-68-2) is a synthetic GLP-1 receptor agonist peptide with 94% sequence homology to human GLP-1. It is commercially known as Ozempic (diabetes) and Wegovy (weight management). Research-grade semaglutide peptide is available for controlled laboratory and R&D use only — not for human or animal consumption.
How many doses does the 8mg semaglutide pen kit contain?
The kit contains 2 pens of 4mg each — 8mg total. At 0.25mg per dose: 32 total doses across both pens. At 0.5mg: 16 doses. At 1mg: 8 doses. The standard research escalation protocol starts at 0.25mg for weeks 1–4, advancing to 0.5mg for weeks 5–8 — supporting a full 12-week window per kit.
Does the semaglutide peptide pen require reconstitution?
No. The Synedica Semaglutide pen is pre-loaded and ready to use — no bacteriostatic water, syringes, or vial measuring required. This is the key advantage over lyophilized semaglutide powder vials sold by most research peptide suppliers.
What is the difference between semaglutide and tirzepatide?
Semaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GLP-1/GIP agonist. Most researchers start with semaglutide to establish single-agonist GLP-1 baseline data before progressing to tirzepatide for dual-pathway comparison. See the Synedica Tirzepatide 40mg Injection Pen Kit for the next step in the GLP research progression.
What is semaglutide also known as?
Semaglutide is the INN (International Nonproprietary Name). Commercially it is known as Ozempic (type 2 diabetes) and Wegovy (weight management/obesity). Its CAS number is 910463-68-2 and molecular formula is C187H291N45O59. The Synedica pen kit contains research-grade semaglutide peptide for laboratory use only.
Should I buy semaglutide or tirzepatide peptide for my research?
Start with semaglutide for single GLP-1 receptor agonism baseline data. Progress to tirzepatide for dual GLP-1/GIP comparison. Progress to retatrutide for triple GLP-1/GIP/Glucagon multi-pathway research. The Synedica pen kit range covers all three compounds in a consistent reconstitution-free format — see the full range at synedica.us/shop.
⚠️ All Synedica products are produced exclusively for controlled laboratory research and development applications. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
